Hims & Hers achieved 136% YoY subscriber growth and unveiled ambitious 2030 goals. Discover how precision medicine drives ...

Hims & Hers, the telehealth and wellness company, has hired a veteran of the autonomous vehicle industry as its next chief ...

Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...

Hims & Hers continues to deliver strong revenue growth. Meanwhile, the company surprised investors by offering a long-term ...

Andrew Dudum cofounded online pharmacy Hims & Hers eight years ago, when he was 27 years old. He’s now the latest to make a ...

The decline in Hims & Hers’ stock price comes as the market reacts to the potential dilution of shares resulting from the ...

Nader Kabbani, who spent almost 20 years at the e-commerce giant, joins the health startup as chief operations officer.

Here are the latest rating downgrades by Seeking Alpha analysts: British American Tobacco (NYSE:BTI). Hold to sell by Michael ...

A post-earnings rally in Hims & Hers Health Inc. has turned co-founder and Chief Executive Officer Andrew Dudum into a weight-loss billionaire.

The FDA has received reports of erectile dysfunction, anxiety, and more after using topical finasteride, a popular hair loss medication. Experts say the medication is still safe for many, but you ...

Investors are worried Novo Nordisk's competition with Eli Lilly is heating up and that the first-to-market GLP-1 leader is ...

Novo Nordisk shares rose after the Danish obesity-drug maker's first-quarter earnings topped Wall Street expectations. As widely anticipated, the drug maker reduced its growth forecast to reflect the ...